Title of article
IL28B polymorphism, explanation for Different Responses to Therapy in Hepatitis C Patients
Author/Authors
Sharafi, Heidar Armin Pathobiology Laboratory, Tehran , Alavian, Moayed Baqiyatallah Research Center for Gastroenterology and Liver Diseases - Baqiyatallah University of Medical Sciences, Tehran
Pages
2
From page
958
To page
959
Abstract
Hepatitis C infection is a major global public health
problem (1). Treatment of hepatitis C with pegylated interferon
α plus Ribavirin as a standard of care (SoC) for
the management of this disease, leads to eradication of
the virus in less than 60% of patients (2). Different sustained
virological response (SVR) rates in different populations
is a challenging fact that has been observed by
researchers and inspired them to search for the causes
(3).
Keywords
Polymorphism , Genetic , Hepatitis C , IL28B Protein , Human
Journal title
Astroparticle Physics
Serial Year
2011
Record number
2424352
Link To Document